Urea,N-(2-chloroethyl)-N'-b-D-glucopyranosyl-N-nitroso-

Suppliers

Names

[ CAS No. ]:
58484-07-4

[ Name ]:
Urea,N-(2-chloroethyl)-N'-b-D-glucopyranosyl-N-nitroso-

[Synonym ]:
ganu

Chemical & Physical Properties

[ Density]:
1.85g/cm3

[ Molecular Formula ]:
C9H16ClN3O7

[ Molecular Weight ]:
313.69200

[ Exact Mass ]:
313.06800

[ PSA ]:
151.92000

[ Index of Refraction ]:
1.664

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
YS4981000
CHEMICAL NAME :
Urea, 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitroso -
CAS REGISTRY NUMBER :
58484-07-4
LAST UPDATED :
199112
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C9-H16-Cl-N3-O7
MOLECULAR WEIGHT :
313.73
WISWESSER LINE NOTATION :
T6OTJ BMVNNO&2G CQ DQ EQ F1Q -B,D-GLU

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
40 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent
TYPE OF TEST :
LD10 - Lethal Dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Tumorigenic - active as anti-cancer agent

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Rodent - mouse Leukocyte
DOSE/DURATION :
10 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 37,783,1977

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 1-(2-chloroethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]urea
  • beta-D-Glucopyranosylamine
  • Diethyl ether
  • o-nitrophenyl N-(2-chloroethyl)-N-nitrosocarbamate
  • Carbon dioxide

DownStream

Related Compounds

  • 3-(2,3-Dimethoxyphenyl)-5-(3-phenylpyrazolidin-4-yl)-1,2,4-oxadiazole
  • N-(2,3-dimethylphenyl)triazolidine-4-carboxamide
  • (2S)-2-phenyl-2-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyacetamide
  • 5-Bromo-1-(2-methoxyethyl)indoline
  • 3-(4-Ethoxy-3-methoxyphenyl)-5-(3-phenylpyrazolidin-4-yl)-1,2,4-oxadiazole
  • 7-[(E)-but-2-enyl]-3-methyl-8-(3-methylbutylsulfanyl)-4,5-dihydropurine-2,6-dione
  • 3-(3,4-Dimethylphenyl)-5-[3-(3-methoxyphenyl)pyrazolidin-4-yl]-1,2,4-oxadiazole
  • 2-[(1,3-dimethyl-2,6-dioxo-7-prop-2-enyl-5H-purin-7-ium-8-yl)sulfanyl]acetamide
  • N-[5-methyl-2-(4-oxo-6-propyl-1,3-diazinan-2-yl)pyrazol-3-yl]quinoxaline-2-carboxamide
  • 4-cyano-N-[5-methyl-2-(4-oxo-6-propyl-1,3-diazinan-2-yl)pyrazol-3-yl]benzamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.